Resorbable lamellar particles of polylactide as adjuvants for influenza virus vaccines

被引:23
|
作者
Coombes, AGA
Major, D
Wood, JM
Hockley, DJ
Minor, PD
Davis, SS
机构
[1] Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England
[2] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
基金
英国医学研究理事会;
关键词
polylactide; adjuvant; adsorption; influenza; vaccine;
D O I
10.1016/S0142-9612(98)00035-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Lamellar particles and microspheres were produced by precipitation from solutions of resorbable, biocompatible, semi-crystalline poly(L-lactide)[PLA] and amorphous poly(DL lactide co-glycolide)[PLG] copolymer, respectively, to investigate their adjuvanticity towards adsorbed influenza virus. Both types of substrate were capable of adsorbing large quantities of virus (>15% w/w) and retaining virus (> 60% of the initial load) over an 8 week time scale in-vitro. Potent immune responses were obtained in mice after the intra-muscular injection of adsorbed vaccine systems. The response to virus adsorbed on PLA lamellar particles was almost five times that obtained using PLG microspheres and fourteen times that using aqueous vaccine. The lamellar forms of PLA may function as an immunomodulator enhancing phagocytic activity due to their irregular shape and may be useful in improving the immune response to a variety of protein and viral antigens. (C) 1998 Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1073 / 1081
页数:9
相关论文
共 50 条
  • [1] Polylactide microparticles as adjuvants for parenteral delivery of influenza virus vaccines
    Wood, JM
    Coombes, AGA
    Major, D
    Minor, PD
    Davis, SS
    OPTIONS FOR THE CONTROL OF INFLUENZA III, 1996, 1123 : 810 - 814
  • [2] Adjuvants in immunization with influenza virus vaccines
    Friedewald, WF
    JOURNAL OF EXPERIMENTAL MEDICINE, 1944, 80 (06): : 477 - 491
  • [3] Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines
    Jabbal-Gill, I
    Lin, W
    Jenkins, P
    Watts, P
    Jimenez, M
    Illum, L
    Davis, SS
    Wood, JM
    Major, D
    Minor, PD
    Li, XW
    Lavelle, EC
    Coombes, AGA
    VACCINE, 1999, 18 (3-4) : 238 - 250
  • [4] Enhancement of the immunizing capacity of influenza virus vaccines with adjuvants
    Friedewald, W. F.
    SCIENCE, 1944, 99 (2579) : 453 - 454
  • [5] Adjuvants in influenza vaccines
    Tetsutani, Kohhei
    Ishii, Ken J.
    VACCINE, 2012, 30 (52) : 7658 - 7661
  • [6] PROTECTION INDUCED BY INACTIVATED INFLUENZA-VIRUS VACCINES WITH POLYMETHYLMETHACRYLATE ADJUVANTS
    KREUTER, J
    LIEHL, E
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1978, 165 (02) : 111 - 117
  • [7] Virus-like particles as universal influenza vaccines
    Kang, Sang-Moo
    Kim, Min-Chul
    Compans, Richard W.
    EXPERT REVIEW OF VACCINES, 2012, 11 (08) : 995 - 1007
  • [8] Influenza vaccines based on virus-like particles
    Kang, Sang-Moo
    Song, Jae-Min
    Quan, Fu-Shi
    Compans, Richard W.
    VIRUS RESEARCH, 2009, 143 (02) : 140 - 146
  • [9] Emulsion-based adjuvants for influenza vaccines
    Vogel, Frederick R.
    Caillet, Catherine
    Kusters, Inca C.
    Haensler, Jean
    EXPERT REVIEW OF VACCINES, 2009, 8 (04) : 483 - 492
  • [10] POTENTIAL ROLE OF IMMUNOLOGICAL ADJUVANTS IN INFLUENZA VACCINES
    HOBSON, D
    POSTGRADUATE MEDICAL JOURNAL, 1973, 49 (569) : 180 - 184